Peptide imaging agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61K 49/00 (2006.01)

Patent

CA 2685553

The present invention relates to labelled cMet binding peptides suitable for optical imaging in vivo. The peptides are labelled with an optical reporter group suitable for imaging in the red to near-infrared region. Also disclosed are pharmaceutical compositions and kits, as well as in vivo imaging methods, especially of use in the detection, staging, diagnosis, monitoring of disease progression or monitoring of treatment of colorectal cancer (CRC).

La présente invention porte sur des peptides de liaison à cMet marqués, appropriés pour une imagerie optique in vivo. Les peptides sont marqués avec un groupe reporteur optique approprié pour une imagerie dans la région rouge ou proche infrarouge. L'invention concerne également des compositions pharmaceutiques et des coffrets, ainsi que des procédés d'imagerie in vivo, notamment utile dans la détection, la stadification, le diagnostic, la surveillance de la progression d'une maladie ou la surveillance d'un traitement du cancer colorectal (CRC).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptide imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide imaging agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1554294

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.